RecruitingNot ApplicableNCT03770338

Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

Effect of 1 Month Preoperative Teriparatide Use on the Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery


Sponsor

The University of Hong Kong

Enrollment

192 participants

Start Date

Mar 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to investigate any difference of insertional torque strength for osteoporotic patients with preoperative 1-month teriparatide injections versus those without. The increased insertional torque of pedicle screws during surgery after only 1 month of teriparatide use has also been studied. However, the effect of teriparatide on vertebral body bone mineral density (BMD) prior to and after fusion surgery has not been studied. The effects on screw insertional torque has also not been studied via a randomized controlled trial method.


Eligibility

Min Age: 40 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether taking teriparatide — a bone-building medication (PTH analog) — before spinal fusion surgery can improve the stability of pedicle screws in patients with osteoporosis. Pedicle screws are used to hold spinal vertebrae together during fusion, but in patients with weak bones, these screws may not grip as firmly. Pre-treating with teriparatide may strengthen the bone and improve surgical outcomes. You may be eligible if: - You have osteoporosis (confirmed by DEXA scan showing bone density more than 2.5 SD below normal, or a history of vertebral/femoral fracture) - You are scheduled for lumbar spinal fusion surgery - You are between 40 and 100 years old You may NOT be eligible if: - You have Paget's disease of bone - You have elevated blood calcium or alkaline phosphatase levels - You have had prior radiation treatment or fusion surgery on your lumbar spine - You have bone tumors or metabolic bone disease other than osteoporosis - You have a known hypersensitivity (allergy) to teriparatide Talk to your spine surgeon and endocrinologist about whether pre-operative teriparatide treatment is appropriate for your osteoporosis-related spinal surgery.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTeriparatide

20ug dosage daily injection, 1-month preoperative


Locations(3)

Jason Pui Yin Cheung

Hong Kong, Please Select An Option Below, Hong Kong

Duchess of Kent Children's Hospital

Hong Kong, Hong Kong

Queen Mary Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03770338


Related Trials